BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37256732)

  • 21. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
    Wei J; Pei S; Zhu X
    Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
    King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
    Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant value of
    Peng H; Chen L; Tang LL; Li WF; Mao YP; Guo R; Zhang Y; Liu LZ; Tian L; Zhang X; Lin XP; Guo Y; Sun Y; Ma J
    Chin J Cancer; 2017 Dec; 36(1):95. PubMed ID: 29258597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of pre-treatment [
    Dong Z; Wang GY; Dai DY; Qin GJ; Tang LL; Xu C; Ma J
    BMC Cancer; 2024 Apr; 24(1):466. PubMed ID: 38622555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
    Wang GH; Lau EW; Shakher R; Binns DS; Hogg A; Drummond E; Hicks RJ
    Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
    Sommer G; Wiese M; Winter L; Lenz C; Klarhöfer M; Forrer F; Lardinois D; Bremerich J
    Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET/CT, Whole-Body MRI, and Coregistered FDG PET/MRI.
    Ohno Y; Yoshikawa T; Takenaka D; Koyama H; Aoyagi K; Yui M; Oshima Y; Hamabuchi N; Tanaka Y; Shigemura C; Oota S; Nomura M; Murayama K; Inui Y; Kikukawa K; Toyama H
    AJR Am J Roentgenol; 2022 May; 218(5):899-908. PubMed ID: 34877872
    [No Abstract]   [Full Text] [Related]  

  • 28. [18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging.
    Liu FY; Chang JT; Wang HM; Liao CT; Kang CJ; Ng SH; Chan SC; Yen TC
    J Clin Oncol; 2006 Feb; 24(4):599-604. PubMed ID: 16446332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-body
    Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
    Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of the COVID-19 pandemic on nasopharyngeal carcinoma extent at FDG PET/MR staging: The NPCOVIPET study.
    Cao C; Xu Y; Qiang M; Tao C; Huang S; Wang L; Chen X
    Head Neck; 2023 Aug; 45(8):1979-1985. PubMed ID: 37260311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.
    Ng SH; Joseph CT; Chan SC; Ko SF; Wang HM; Liao CT; Chang YC; Lin WJ; Fu YK; Yen TC
    J Nucl Med; 2004 Oct; 45(10):1669-76. PubMed ID: 15471831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
    Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
    Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is unenhanced 18F-FDG-PET/CT better than enhanced CT in the detection of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma?
    Wu IS; Hung GU; Chang BL; Liu CK; Chang TH; Lee HS; Chen MK
    Ear Nose Throat J; 2016; 95(4-5):178-84. PubMed ID: 27140019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
    Verboom P; van Tinteren H; Hoekstra OS; Smit EF; van den Bergh JH; Schreurs AJ; Stallaert RA; van Velthoven PC; Comans EF; Diepenhorst FW; van Mourik JC; Postmus PE; Boers M; Grijseels EW; Teule GJ; Uyl-de Groot CA;
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1444-9. PubMed ID: 14579081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR.
    Piao Y; Cao C; Xu Y; Huang S; Jiang F; Jin T; Jin Q; Hua Y; Hu Q; Chen X
    Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):353-359. PubMed ID: 33782748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [
    Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
    Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.
    Ng SH; Chan SC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Lin CY; Chang KP; Lin YC
    Eur Radiol; 2010 Sep; 20(9):2229-40. PubMed ID: 20393714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of the post-radiotherapy
    Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
    Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.